Same Indication

Memantine vs Tofacitinib

Memantine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Memantine and Tofacitinib.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Memantine β€” 60-80 hours; Tofacitinib β€” 3.2 hours.

Chemical Properties

Molecular Formula: Memantine β€” C12H21N; Tofacitinib β€” C16H20N6O.

Molecular Weight: Memantine β€” 179.3080 g/mol; Tofacitinib β€” 312.3700 g/mol.

Type: Memantine β€” Small molecule; Tofacitinib β€” Small molecule.